PrintPrintEmailEmail
Friedman Faculty - Lamon-Fava
Stefania Lamon-Fava
Associate Professor, Friedman School of Nutrition Science and Policy
Scientist I, Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging
Education:
  • Ph.D. in Molecular Biology and Cellular Pathology, University of Modena
  • M.D., University of Padua School of Medicine
Contact Information
Phone: 
(617) 556-3105
Fax: 
(617) 556-3013
Email: 
stefania.lamon-fava@tufts.edu
Professional Affiliations

Member, Massachusetts Medical Society; Fellow, American Heart Association

Select Recent Publications
Kuang {Y, Paulson EK, Lichtenstein AH, Matthan NR, Lamon-Fava S. Docosahexaenoic acid suppresses apolipoprotein A-I gene expression through hepatocyte nuclear factor-3β. The American Journal of Clinical Nutrition. 2011;94:594-600. Abstract
Lamon-Fava S, Marcovina SM, Albers JJ, Kennedy H, deLuca C, White CC, et al. Lipoprotein(a) levels, apolipoprotein(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study. Journal of Lipid Research. 2011. Abstract
Corcoran MP, Lichtenstein AH, Meydani M, Dillard A, Schaefer EJ, Lamon-Fava S. The effect of 17beta-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu. Journal of Molecular Endocrinology. 2011;47:109-17. Abstract
Lamon-Fava S, Asztalos BF, Howard TD, Reboussin DM, Horvath KV, Schaefer EJ, et al. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women. Clinical Endocrinology. 2010;72:169-75. Abstract
Lamon-Fava S, Herrington DM, Horvath KV, Schaefer EJ, Asztalos BF. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism: Clinical and Experimental. 2010;59:1794-800. Abstract
more »